Evaluation of lncRNA FOXD3-AS1 as a Biomarker for Early-Stage Lung Cancer Diagnosis and Subtype Identification

PURPOSE: Lung cancer (LC) is the most commonly diagnosed cancer and the leading cause of cancer-related deaths. More and more long noncoding RNA (lncRNA) are associated with cancer. This study aimed to assess whether plasma lncRNA could be used to diagnose early-stage LC and identify subtypes of LC....

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiaofeng, Chen, Wenyan, Qi, Yu, Zhu, Yongqian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492367/
https://www.ncbi.nlm.nih.gov/pubmed/36159563
http://dx.doi.org/10.1155/2022/5702014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492367/
https://www.ncbi.nlm.nih.gov/pubmed/36159563
http://dx.doi.org/10.1155/2022/5702014

Ejemplares similares